References
- Suda Y, Suzuki M, Ikawa Y and Aizawa S (1987) Mouse embryonic stem cells exhibit indefinite proliferative potential. J Cell Physiol 133, 197-201 https://doi.org/10.1002/jcp.1041330127
- Niwa H (2007) How is pluripotency determined and maintained? Development 134, 635-646 https://doi.org/10.1242/dev.02787
- Chambers I, Colby D, Robertson M et al (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655 https://doi.org/10.1016/S0092-8674(03)00392-1
- Mitsui K, Tokuzawa Y, Itoh H et al (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642 https://doi.org/10.1016/S0092-8674(03)00393-3
- Boyer LA, Lee TI, Cole MF et al (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 https://doi.org/10.1016/j.cell.2005.08.020
- Chambers I, Silva J, Colby D et al (2007) Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230-1234 https://doi.org/10.1038/nature06403
- Kuroda T, Tada M, Kubota H et al (2005) Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 25, 2475-2485 https://doi.org/10.1128/MCB.25.6.2475-2485.2005
- Rodda DJ, Chew JL, Lim LH et al (2005) Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 280, 24731-24737 https://doi.org/10.1074/jbc.M502573200
- van den Berg DL, Zhang W, Yates A et al (2008) Estrogen-related receptor beta interacts with Oct4 to positively regulate Nanog gene expression. Mol Cell Biol 28, 5986-5995 https://doi.org/10.1128/MCB.00301-08
- Ohno H, Takimoto G and McKeithan TW (1990) The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60, 991-997 https://doi.org/10.1016/0092-8674(90)90347-H
- Maldonado V and Melendez-Zajgla J (2011) Role of Bcl-3 in solid tumors. Mol Cancer 10, 152 https://doi.org/10.1186/1476-4598-10-152
- Fujita T, Nolan GP, Liou HC, Scott ML and Baltimore D (1993) The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev 7, 1354-1363 https://doi.org/10.1101/gad.7.7b.1354
- Inoue J, Takahara T, Akizawa T and Hino O (1993) Bcl-3, a member of the I kappa B proteins, has distinct specificity towards the Rel family of proteins. Oncogene 8, 2067-2073
-
Na S-Y, Choi J-E, Kim H-J, Jhun BH, Lee Y-C and Lee JW (1999) Bcl3, an
$l{\kappa}B$ protein, stimulates activating protein-1 transactivation and cellular proliferation. J Biol Chem 274, 28491-28496 https://doi.org/10.1074/jbc.274.40.28491 -
Na S-Y, Choi H-S, Kim JW, Na DS and Lee JW (1998) Bcl3, an
$l{\kappa}B$ protein, as a novel transcription coactivator of the retinoid X receptor. J Biol Chem 273, 30933-30938 https://doi.org/10.1074/jbc.273.47.30933 - Hishiki T, Ohshima T, Ego T and Shimotohno K (2007) BCL3 acts as a negative regulator of transcription from the human T-cell leukemia virus type 1 long terminal repeat through interactions with TORC3. J Biol Chem 282, 28335-28343 https://doi.org/10.1074/jbc.M702656200
- Chen CY, Lee DS, Yan YT et al (2015) Bcl3 Bridges LIF-STAT3 to Oct4 Signaling in the Maintenance of Naive Pluripotency. Stem Cells 33, 3468-3480 https://doi.org/10.1002/stem.2201
-
Bours V, Franzoso G, Azarenko V et al (1993) The oncoprotein Bcl-3 directly transactivates through
${\kappa}B$ motifs via association with DNA-binding p50B homodimers. Cell 72, 729-739 https://doi.org/10.1016/0092-8674(93)90401-B -
Park SG, Chung C, Kang H, Kim J-Y and Jung G (2006) Up-regulation of cyclin D1 by HBx is mediated by NF-
${\kappa}B2$ /BCL3 complex through${\kappa}B$ site of cyclin D1 promoter. J Biol Chem 281, 31770-31777 https://doi.org/10.1074/jbc.M603194200 - Loh YH, Wu Q, Chew JL et al (2006) The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38, 431-440 https://doi.org/10.1038/ng1760
-
Jamaluddin M, Choudhary S, Wang S et al (2005) Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-
${\kappa}B$ signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter. J Virol 79, 15302-15313 https://doi.org/10.1128/JVI.79.24.15302-15313.2005 -
Yang J, Williams RS and Kelly DP (2009) Bcl3 interacts cooperatively with peroxisome proliferator-activated receptor gamma (
$PPAR{\gamma}$ ) coactivator$1{\alpha}$ to coactivate nuclear receptors estrogen-related receptor${\alpha}$ and$PPAR{\alpha}$ . Mol Cell Biol 29, 4091-4102 https://doi.org/10.1128/MCB.01669-08 - Viatour P, Dejardin E, Warnier M et al (2004) GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. Mol Cell 16, 35-45 https://doi.org/10.1016/j.molcel.2004.09.004
- Lin T, Chao C, Saito S et al (2005) p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7, 165-171 https://doi.org/10.1038/ncb1211